Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 190

1.

Nitric oxide modulation of renal and cardiac hemodynamics in type 2 diabetes.

Dalla Vestra M, Sacerdoti D, Bombonato G, Fioretto P, Finucci G, Saller A, Sfriso A, Bruseghin M, Sambataro M, Velussi M, Baggio B, Nosadini R, Crepaldi G.

Eur J Endocrinol. 2002 May;146(5):687-94.

PMID:
11980625
[PubMed - indexed for MEDLINE]
Free Article
2.

L-arginine-induced vasodilation of the renal vasculature is not altered in hypertensive patients with type 2 diabetes.

Delles C, Schneider MP, Oehmer S, Fleischmann EH, Schmieder RE.

Diabetes Care. 2003 Jun;26(6):1836-40.

PMID:
12766119
[PubMed - indexed for MEDLINE]
3.

Nifedipine attenuates systemic and renal vasoconstriction during nitric oxide inhibition in humans.

Dijkhorst-Oei LT, Rabelink TJ, Boer P, Koomans HA.

Hypertension. 1997 May;29(5):1192-8.

PMID:
9149686
[PubMed - indexed for MEDLINE]
Free Article
4.

Enhanced sodium retention after acute nitric oxide blockade in mildly sodium loaded patients with essential hypertension.

Bech JN, Nielsen EH, Pedersen RS, Svendsen KB, Pedersen EB.

Am J Hypertens. 2007 Mar;20(3):287-95.

PMID:
17324742
[PubMed - indexed for MEDLINE]
5.

Assessment of endothelial function of the renal vasculature in human subjects.

Delles C, Jacobi J, Schlaich MP, John S, Schmieder RE.

Am J Hypertens. 2002 Jan;15(1 Pt 1):3-9.

PMID:
11824856
[PubMed - indexed for MEDLINE]
6.

Gender is related to alterations of renal endothelial function in type 2 diabetes.

Schneider MP, Ritt M, Raff U, Ott C, Schmieder RE.

Nephrol Dial Transplant. 2009 Nov;24(11):3354-9. doi: 10.1093/ndt/gfp318. Epub 2009 Jun 30.

PMID:
19567476
[PubMed - indexed for MEDLINE]
Free Article
7.

Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients.

Pistrosch F, Herbrig K, Kindel B, Passauer J, Fischer S, Gross P.

Diabetes. 2005 Jul;54(7):2206-11.

PMID:
15983223
[PubMed - indexed for MEDLINE]
Free Article
8.

Acute effects of nitric oxide synthase inhibition on systemic, hepatic, and renal hemodynamics in patients with cirrhosis and ascites.

Spahr L, Martin PY, Giostra E, Niederberger M, Lang U, Capponi A, Hadengue A.

J Investig Med. 2002 Mar;50(2):116-24.

PMID:
11928940
[PubMed - indexed for MEDLINE]
9.

Impact of the endothelial nitric oxide synthase gene G894T polymorphism on renal endothelial function in patients with type 2 diabetes.

Ritt M, Ott C, Delles C, Schneider MP, Schmieder RE.

Pharmacogenet Genomics. 2008 Aug;18(8):699-707. doi: 10.1097/FPC.0b013e32830500b1.

PMID:
18622262
[PubMed - indexed for MEDLINE]
10.

Increased response of renal perfusion to the antioxidant vitamin C in type 2 diabetes.

Delles C, Schneider MP, Oehmer S, Fleischmann I, Fleischmann EF, Schmieder RE.

Nephrol Dial Transplant. 2004 Oct;19(10):2513-8. Epub 2004 Jul 20.

PMID:
15266036
[PubMed - indexed for MEDLINE]
Free Article
11.

Physiological role of nitric oxide in regulation of renal function in humans.

Haynes WG, Hand MF, Dockrell ME, Eadington DW, Lee MR, Hussein Z, Benjamin N, Webb DJ.

Am J Physiol. 1997 Mar;272(3 Pt 2):F364-71.

PMID:
9087680
[PubMed - indexed for MEDLINE]
12.

Changes in renal and systemic hemodynamics after NO-synthase inhibition in males with family history of hypertension.

Berger ED, Bader BD, Rüb N, Rauscher MA, Rebenschütz I, Gaber OC, Enderle MD, Risler T, Erley CM.

Kidney Blood Press Res. 2002;25(1):42-9.

PMID:
11834876
[PubMed - indexed for MEDLINE]
13.

Dietary sodium affects systemic and renal hemodynamic response to NO inhibition in healthy humans.

Bech JN, Nielsen CB, Ivarsen P, Jensen KT, Pedersen EB.

Am J Physiol. 1998 May;274(5 Pt 2):F914-23.

PMID:
9612329
[PubMed - indexed for MEDLINE]
Free Article
14.

Impact of NO-synthase inhibition on renal hemodynamics in normotensive and hypertensive subjects.

Jacobi J, Schneider MP, John S, Schmieder RE.

J Hypertens. 2002 Mar;20(3):525-30.

PMID:
11875321
[PubMed - indexed for MEDLINE]
15.

Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis.

La Villa G, Barletta G, Pantaleo P, Del Bene R, Vizzutti F, Vecchiarino S, Masini E, Perfetto F, Tarquini R, Gentilini P, Laffi G.

Hepatology. 2001 Jul;34(1):19-27.

PMID:
11431729
[PubMed - indexed for MEDLINE]
16.

Effects of systemic NO synthesis inhibition on RPF, GFR, UNa, and vasoactive hormones in healthy humans.

Bech JN, Nielsen CB, Pedersen EB.

Am J Physiol. 1996 May;270(5 Pt 2):F845-51.

PMID:
8928847
[PubMed - indexed for MEDLINE]
17.

Impaired basal NO activity in patients with glomerular disease and the influence of oxidative stress.

Schäufele TG, Schlaich MP, Delles C, Klingbeil AU, Fleischmann EH, Schmieder RE.

Kidney Int. 2006 Sep;70(6):1177-81. Epub 2006 Aug 2.

PMID:
16883318
[PubMed - indexed for MEDLINE]
18.

Effects of nitric oxide blockade and cyclosporin A on cardiovascular and renal function in normal man.

Hansen JM, Johansen NJ, Mollerup HM, Fogh-Andersen N, Strandgaard S.

J Hypertens. 1999 Dec;17(12 Pt 1):1707-13.

PMID:
10658936
[PubMed - indexed for MEDLINE]
19.

The renal and systemic hemodynamic effects of a nitric oxide-synthase inhibitor are reversed by a selective endothelin(a) receptor antagonist in men.

Schmidt A, Bayerle-Eder M, Pleiner H, Zeisner C, Wolzt M, Mayer G, Schmetterer L.

Nitric Oxide. 2001 Aug;5(4):370-6.

PMID:
11485375
[PubMed - indexed for MEDLINE]
20.

Effect of nitric oxide synthase inhibition on renal hemodynamics in humans: reversal by L-arginine.

Wolzt M, Schmetterer L, Ferber W, Artner E, Mensik C, Eichler HG, Krejcy K.

Am J Physiol. 1997 Feb;272(2 Pt 2):F178-82.

PMID:
9124393
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk